Research Article
The Oncofetal Protein IMP3: A Novel Grading Tool and Predictor of Poor Clinical Outcome in Human Gliomas
Table 3
The Oncomine repository1 was queried for IMP3 (IGF2BP3) differential expression in brain cancers and only studies performed on human tissues were considered. The name of the study, the samples for which the comparison was significant2, the relative expression difference (fold change), and the associated value ( statistic provided within the database) are reported.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
https://www.oncomine.org/resource/login.html. value less than . 3GBM: glioblastoma; OD: oligodendroglioma. 4GEX: gene expression analysis; CNV: DNA copy number variation analysis. |